Sintilimab-induced autoimmune diabetes mellitus manifesting as diabetic ketoacidosis in a patient with advanced esophageal squamous cell carcinoma.

Authors :: Lai N
Fan X
Liu S
Source :: Acta diabetologica [Acta Diabetol] 2024 May; Vol. 61 (5), pp. 675-678. Date of Electronic Publication: 2024 Feb 09.
Publication Year :: 2024

Subjects :: Humans
Antibodies, Monoclonal, Humanized adverse effects
Antibodies, Monoclonal, Humanized therapeutic use
Diabetes Mellitus, Type 1 complications
Diabetes Mellitus, Type 1 drug therapy
Diabetic Ketoacidosis chemically induced
Esophageal Neoplasms drug therapy
Esophageal Squamous Cell Carcinoma drug therapy

Full Text Access

Tools